^
    Back
    Association details:
    Biomarker:No biomarker
    Cancer:Prostate Cancer
    Drug:zoledronic acid (Osteoclast inhibitor, Bone resorption factor inhibitor)
    Direction:Sensitive
    Evidence:
    Evidence Level:
    Sensitive: A1 - Approval
    New
    Source:
    FDA
    Excerpt:
    Zometa is a bisphosphonate indicated for the treatment of:…Prostate cancer should have progressed after treatment with at least one hormonal therapy.